These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32576554)

  • 1. Reconsidering the scope of US state laws allowing pharmacist substitution of generic drugs.
    Darrow JJ; Chong JE; Kesselheim AS
    BMJ; 2020 Jun; 369():m2236. PubMed ID: 32576554
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of state-level pharmacist regulations on generic substitution of prescription drugs.
    Song Y; Barthold D
    Health Econ; 2018 Nov; 27(11):1717-1737. PubMed ID: 29992674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State Approaches to Therapeutic Interchange in Community Pharmacy Settings: Legislative and Regulatory Authority.
    Vanderholm T; Klepser D; Adams AJ
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1260-1263. PubMed ID: 30479203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution laws, insurance coverage, and generic drug use.
    Anis AH
    Med Care; 1994 Mar; 32(3):240-56. PubMed ID: 8145601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceuticals issue brief: generic and therapeutic substitution: year end report--2004.
    Health Policy Tracking Service staff
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-14. PubMed ID: 15724310
    [No Abstract]   [Full Text] [Related]  

  • 6. Generic clopidogrel: time to substitute?
    Doll J; Zeitler E; Becker R
    JAMA; 2013 Jul; 310(2):145-6. PubMed ID: 23839745
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug product selection: legal issues.
    Christensen TP; Kirking DM; Ascione FJ; Welage LS; Gaither CA
    J Am Pharm Assoc (Wash); 2001; 41(6):868-74. PubMed ID: 11765112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress of pharmacist collaborative practice: status of state laws and regulations and perceived impact of collaborative practice.
    Punekar Y; Lin SW; Thomas J
    J Am Pharm Assoc (2003); 2003; 43(4):503-10. PubMed ID: 12952315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic drugs in dermatology: part II.
    Payette M; Grant-Kels JM
    J Am Acad Dermatol; 2012 Mar; 66(3):353.e1-15; quiz 367-8. PubMed ID: 22342022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The outlook for pharmacist initiation and modification of drug therapy.
    Shefcheck SL; Thomas J
    J Am Pharm Assoc (Wash); 1996 Oct; NS36(10):597-604. PubMed ID: 8908936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituting generic drugs: state roles.
    Cauchi R
    NCSL Legisbrief; 2009; 17(25):1-2. PubMed ID: 19526654
    [No Abstract]   [Full Text] [Related]  

  • 12. Consideration of international generic distribution policies on patient outcomes in the United States and Germany.
    Saverno K; Gothe H; Schuessel K; Biskupiak J; Schulz M; Siebert U; Brixner D
    Pharmazie; 2014 Mar; 69(3):238-40. PubMed ID: 24716417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of differences in state drug product selection laws on pharmacists' substitution behavior.
    Carroll NV; Fincham JE; Cox FM
    Med Care; 1987 Nov; 25(11):1069-77. PubMed ID: 3695637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring factors underlying the attitude of community pharmacists to generic substitution: a nationwide study from Poland.
    Drozdowska A; Hermanowski T
    Int J Clin Pharm; 2016 Feb; 38(1):162-70. PubMed ID: 26620450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' experiences and attitudes regarding generic drugs and generic substitution: two sides of the coin.
    Olsson E; Kälvemark Sporrong S
    Int J Pharm Pract; 2012 Dec; 20(6):377-83. PubMed ID: 23134096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review of Physicians' and Pharmacists' Perspectives on Generic Drug Use: What are the Global Challenges?
    Toverud EL; Hartmann K; Håkonsen H
    Appl Health Econ Health Policy; 2015 Aug; 13 Suppl 1(Suppl 1):S35-45. PubMed ID: 25963230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generic drugs for the treatment of ocular conditions: changing the treatment landscape.
    Aref AA
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):551-3. PubMed ID: 24957466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Tyranny of Generic Immunosuppressants.
    Ravichandran B; Weir MR
    Am J Nephrol; 2016; 44(3):204-5. PubMed ID: 27576500
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions.
    Sacks CA; Van de Wiele VL; Fulchino LA; Patel L; Kesselheim AS; Sarpatwari A
    JAMA Intern Med; 2021 Jan; 181(1):16-22. PubMed ID: 32865564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are advanced practice pharmacist designations really advanced?
    Frost TP; Adams AJ
    Res Social Adm Pharm; 2018 May; 14(5):501-504. PubMed ID: 29097045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.